IG20, a MADD Splice Variant, Increases Cell Susceptibility to γ-Irradiation and Induces Soluble Mediators That Suppress Tumor Cell Growth

Cancer Research

Volumn 63, Issue 24, 2003, Pages 8768-8776

  Efimova, Elena ^a   Martinez, Osvaldo ^a   Lokshin, Anna ^b   Arima, Takayasu ^a   Prabhakar, Bellur S ^a,c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c Building 935 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DNA HELICASE I; ETOPOSIDE; GUANINE NUCLEOTIDE EXCHANGE FACTOR; HELICASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; ISOPROTEIN; MADD PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VINBLASTINE;

ALTERNATIVE RNA SPLICING; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CANCER; CANCER INHIBITION; CANCER PREVENTION; CARCINOGENESIS; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIVISION; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; GAMMA IRRADIATION; GAMMA RADIATION; GENE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GENETICS; HELA CELL; HUMAN; HUMAN CELL; IG20 GENE; METABOLISM; OVARY CANCER; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR CELL CULTURE; TUMOR CELL LINE; TUMOR GROWTH;

ALTERNATIVE SPLICING; APOPTOSIS; CELL DIVISION; CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; DNA HELICASES; ESCHERICHIA COLI PROTEINS; FEMALE; GAMMA RAYS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HELA CELLS; HUMANS; INTERLEUKIN-6; OVARIAN NEOPLASMS; PROTEIN ISOFORMS; RADIATION TOLERANCE; TRANSFECTION;

EID: 0347951247     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Al-Zoubi, A. M., Efimova, E. V., Kaithamana, S., Martinez, O., El-Idrissi Mel-A, Dogan, R. E., and Prabhakar, B. S. Contrasting effects of IG20 and its isoforms, MADD and DENN-SV, on tumor necrosis factor α-induced apoptosis and activation of caspase 8 and 3. J. Biol. Chem., 276: 47202-47211, 2001.
2. Cunningham, S. J. Cloning and characterization of a novel cDNA isolated from human β cells (Thesis). Galveston, TX: University of Texas Medical Branch, Graduate School of Biomedical Sciences, 1996.
3. Chow, V. T. K., and Lee, S. S. DENN, a novel human gene differentially expressed in normal and neoplastic cells. DNA Sequence, 6: 263-273, 1996.
4. Efimova, E. V., Al-Zoubi, A. M., Martinez, O., Arima, T., Kaithamana, S., Lu, S. F., and Prabhakar, B. S. Different effects of IG20 and DENN-SV (MADD splice variants) on proliferation and induced apoptosis of cancer cells. Oncogene, in press, 2003.
5. Luch, A. Cell cycle control and cell division: implications for chemically induced carcinogenesis. ChemBioChem., 3: 506-516, 2002.
6. Merritt, A. J., Allen, T. D., Potten, C. S., and Hickman, J. A. Apoptosis in small intestinal epithelial from p53-null mice: evidence for a delayed, p53-independent G2/M-associated cell death after γ-irradiation. Oncogene, 14: 2759-2766, 1997.
7. Strasser, A., Harris, A. W., Jacks, T., and Cory, S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell, 79: 329-339, 1994.
8. Wei, L. H., Kuo, M. L., Chen, C. A., Chou, C. H., Cheng, W. F., Chang, M. C., Su, J. L., and Hsieh, C. Y. The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI3-K/Akt pathway. Oncogene, 20: 5799-5809, 2001.
9. Wei, L. H., Kuo, M. L., Chen, C. A., Chou, C. H., Lai, K. B., Lee, C. N., and Hsieh, C. Y. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene, 22: 1517-1527, 2003.
10. Asschert, J. G., Vellenga, E., Hollema, H., van der Zee, A. G., and de Vries, E. G. Expression of macrophage colony-stimulating factor (M-CSF), interleukin-6 (IL-6), interleukin-1β (IL-1β, interleukin-11 (IL-11) and tumor necrosis factor-α (TNF-α) in p53-characterised human ovarian carcinomas. Eur. J. Cancer, 33: 2246-2251, 1997.
11. Asschert, J. G., Vellenga, E., Ruiters, M. H., and de Vries. E. G. Regulation of spontaneous and TNF/IFN-induced IL-6 expression in two human ovarian-carcinoma cell lines. Int. J. Cancer, 82: 244-249, 1999.
12. Nash, M. A., Ferrandina, G.. Gordinier. M., Loercher, A., and Freedman, R. S. The role of cytokines in both the normal and malignant ovary. Endocr. Relat. Cancer, 6: 93-107, 1999.
13. Seppanen, M., Lin, L., Punnonen, J., Grenman, S., Punnonen, R., and Vihko, K. K. Regulation of UT-OC-3 ovarian carcinoma cells by cytokines: inhibitory effects on cell proliferation and activation of transcription factors AP-1 and NF-κB. Eur. J. Endocrinol., 142: 393-401, 2000.
14. Florenes, V. A., Lu, C., Bhattacharya, N., Rak, J., Sheehan, C., Slingerland, J. M., and Kerbel, R. S. Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma. Oncogene, 18: 1023-1032, 1999.
15. Mori, S., Murakami-Mori, K., and Bonavida, B. Interleuk-in-6 induces G1 arrest through induction of p27 (Kip1), a cyclin-dependent kinase inhibitor, and neuron-like morphology in LNCaP prostate tumor cells. Biochem. Biophys. Res. Commun., 257: 609-614, 1999.
16. Amanullah, A., Hoffman, B., and Liebermann, D. A. Deregulated E2F-1 blocks terminal differentiation and loss of leukemogenicity of M1 myeloblastic leukemia cells without abrogating induction of p15(INK4B) and p16(INK4A). Blood, 96: 475-482, 2000.
17. Narimatsu, M., Nakajima, K., Ichiba, M., and Hirano, T. Association of Stat3-dependent transcriptional activation of p19INK4D with IL-6-induced growth arrest. Biochem. Biophys. Res. Commun., 238: 764-768, 1997.
18. Cornil, I., Theodorescu, D., Man, S., Herlyn, M., Jambrosic, J., and Kerbel, R. S. Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc. Natl. Acad. Sci. USA. 88: 6028-6032, 1991.
19. Lu, C., and Kerbel, R. S. Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression. J. Cell Biol., 120: 1281-1288, 1993.
20. Ray, A., Sassone-Corsi, P., and Sehgal, P. B. A multiple cytokine- and second messenger-responsive element in the enhancer of the human interleukin-6 gene: similarities with c-fos gene regulation. Mol. Cell. Biol., 9: 5537-5547, 1989.
21. Akira, S., Isshiki, H., Sugita, T., Tanabe, O., Kinoshita, S., Nishio, Y., Nakajima, T., Hirano, T., and Kishimoto, T. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J., 9: 1897-1906, 1990.
22. Shimizu, H., Mitomo, K., Watanabe, T., Okamoto, S., and Yamamoto, K. Involvement of a NF-κB-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines. Mol. Cell. Biol., 10: 561-568, 1990.
23. Libermann, T. A., and Baltimore, D. Activation of interleukin-6 gene expression through the NF-κB transcription factor. Mol. Cell. Biol., 10: 2327-2334, 1990.
24. Petak, I., and Houghton, J. A. Shared pathways: death receptors and cytotoxic drugs in cancer therapy. Pathol. Oncol. Res., 7: 95-106, 2001.
25. Guan, B., Yue, P., Clayman, G. L., and Sun, S. Y. Evidence that the death receptor DR4 is a DNA damage-inducible, p53-regulated gene. J. Cell. Physiol., 188: 98-105, 2001.
26. Nagane, M., Pan, G., Weddle, J. J., Dixit, V. M., Cavenee, W. K., and Huang, H. J. Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo. Cancer Res., 60: 847-853, 2000.
27. Vivo, C., Liu, W., and Broaddus, V. C. c-Jun N-terminal kinas contributes to apoptotic synergy induced by TRAIL plus DNA damage in chemoresistant, p53 inactive mesothelioma cells. J. Biol. Chem., 278: 25461-25467, 2003.